Sancilio Pharmaceuticals Company, Inc.
http://www.sancilio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sancilio Pharmaceuticals Company, Inc.
News We’re Watching: CDRH Announces Cybersecurity Collaboration, Electrostim Faces Lawsuit, FDA Recalls And Approvals
This week, the FDA extended a comment period on digital health tools to detect diabetes; Theradaptive launched a trial of its spinal fusion device; and devices from Hologic and GE Healthcare won FDA clearance.
Pipeline Watch: Phase III Progress With Keytruda, Bempedoic Acid And Ubrogepant
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch: Patisiran, Etrolizumab, ALKS8700 Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch: Phase III Starts With Rimegepant, ARQ087 And SGX942
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Company Information
- Industry
-
Pharmaceuticals
- OTC, Consumer
- Other Names / Subsidiaries
-
- Sancilio & Company, Inc.
- Sancilio and Company, Inc.
- SCI
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice